REGULATED PRESS RELEASE published on 08/28/2025 at 07:00, 3 months 8 days ago Biophytis obtient l’autorisation de l’EMA et des autorités belges pour démarrer son essai clinique de phase 3 dans la sarcopénie Biophytis obtient l’autorisation de l’EMA et des autorités belges pour démarrer son essai clinique de phase 3 dans la sarcopénie. La société se prépare à recruter des patients pour cette étude majeure Biophytis Essai Clinique Sarcopénie Autorisation EMA
PRESS RELEASE published on 08/28/2025 at 06:59, 3 months 8 days ago Biophytis obtient l’autorisation de l’EMA et des autorités belges pour démarrer son essai clinique de phase 3 dans la sarcopénie Biophytis obtient l’autorisation de l’EMA et des autorités belges pour démarrer son essai clinique de phase 3 dans la sarcopénie. Étape majeure dans le développement de thérapies pour la perte musculaire liée à l’âge Biophytis Essai Clinique Sarcopénie Autorisation EMA
PRESS RELEASE published on 08/28/2025 at 06:59, 3 months 8 days ago Biophytis Receives EMA and Belgian Regulatory Approval to Initiate Phase 3 Sarcopenia Clinical Trial Biophytis receives EMA and Belgian regulatory approval for Phase 3 sarcopenia clinical trial, enabling patient enrolment in Belgium and collaboration with European centers Biophytis Sarcopenia Phase 3 EMA Approval Belgian Regulatory Approval
BRIEF published on 08/05/2025 at 23:05, 3 months 30 days ago Biophytis assure 1 million d'euros de financement obligataire Biophytis Dilution Actionnaires Financement Obligataire Hexagon Capital Fund OBA101 Développement
BRIEF published on 08/05/2025 at 23:05, 3 months 30 days ago Biophytis Secures €1 Million Non-Dilutive Bond Financing Biophytis Bond Financing Shareholder Impact Non-dilutive OBA101 Program
REGULATED PRESS RELEASE published on 08/05/2025 at 23:00, 3 months 30 days ago Biophytis Secures Non-Dilutive Bond Financing Line of up to €1 Million Biophytis secures a non-dilutive bond financing line of up to €1 million with Hexagon Capital Fund to support OBA101 program development and strengthen cash position Biophytis Financing Hexagon Capital Fund OBA101 Program Non-dilutive Bond
REGULATED PRESS RELEASE published on 08/05/2025 at 23:00, 3 months 30 days ago Biophytis sécurise une ligne de financement obligataire non dilutive jusqu’à 1 M€ Biophytis sécurise une ligne de financement obligataire non dilutive jusqu’à 1 M€ avec Hexagon Capital Fund pour financer le programme OBA101 et couvrir ses besoins jusqu’au premier trimestre 2026 Biophytis Trésorerie Financement Obligataire Hexagon Capital Fund OBA101
PRESS RELEASE published on 08/05/2025 at 22:59, 3 months 30 days ago Biophytis sécurise une ligne de financement obligataire non dilutive jusqu’à 1 M€ Biophytis sécurise une ligne de financement obligataire non dilutive de 1 M€ avec Hexagon Capital Fund pour financer le développement clinique du programme OBA101 jusqu'au T1 2026 Biophytis Obligataire Hexagon Capital Fund Ligne De Financement Dilutive
PRESS RELEASE published on 08/05/2025 at 22:59, 3 months 30 days ago Biophytis Secures Non-Dilutive Bond Financing Line of up to €1 Million Biophytis secures a non-dilutive bond financing line of up to €1 million from Hexagon Capital Fund. The bonds, with 12% annual interest rate, will mature in 24 months and may be repaid in shares Biophytis Hexagon Capital Fund Non-dilutive Bond Financing 12% Interest Rate Repayment In Shares
BRIEF published on 07/30/2025 at 07:05, 4 months 6 days ago Biophytis Joins Silver Innov' to Boost Silver Economy Initiatives Biophytis Healthcare Innovation Longevity Sarcopenia Silver Innov'
Published on 12/05/2025 at 15:00, 24 minutes ago Calidi Biotherapeutics and Nova Minerals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Published on 12/05/2025 at 14:00, 1 hour 24 minutes ago Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 1 hour 24 minutes ago Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange
Published on 12/05/2025 at 02:35, 12 hours 49 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 15:05, 19 minutes ago Seegene Establishes French Subsidiary to Expand European Footprint
Published on 12/05/2025 at 14:22, 1 hour 2 minutes ago EQS-Adhoc: Jungheinrich AG: Jungheinrich expects to complete sale of its Russian subsidiary in 2026 and adjusts forecast for the 2025 financial year
Published on 12/05/2025 at 14:16, 1 hour 7 minutes ago Advanced Blockchain AG: Successful Completion of Token Generation Event of Portfolio company Talisman
Published on 12/05/2025 at 14:10, 1 hour 14 minutes ago The Kingdom of Saudi Arabia Launches a New Official Platform, "Saudi Properties", Ahead of the Non-Saudi Property Ownership Law
Published on 12/05/2025 at 13:45, 1 hour 39 minutes ago BingX Introduces Recurring Buy to Help Users Ride Out Crypto Market Swings
Published on 12/05/2025 at 15:10, 13 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 13 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 1 hour 26 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 6 hours 39 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 6 hours 39 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry